Prilocaine Hydrochloride

盐酸丙胺卡因

Report date: 2026/04/06 20:01:48
NME

Base Information

Drug NamePrilocaine Hydrochloride
Drug Alias NamePropitocaine hydrochloride盐酸丙安卡因prilocainum丙胺卡因盐酸盐Takipril +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockersVoltage-gated calcium channel blockers
TargetsSodium channel alpha subunitVoltage-gated calcium channel
Therapy Area/IndicationsPainHyperemesis GravidarumCompartment Syndromes +[4] 
Global Approved IndicationsHyperemesis GravidarumAnesthesia
Approved Indications in ChinaHyperemesis Gravidarum
Original Approved Country/TerritoryUnited States
Original Approved Date1965/11/18
Country/TerritoryUnited StatesEgyptBrazil +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesCairo UniversityJumpcan Pharmaceutical Group Co Ltd
Inactive CompaniesThe Brigham and Women's HospitalAstrazeneca PlcLoyola University +[4] 
Active IndicationsHyperemesis GravidarumAnesthesia
Inactive IndicationsPainCompartment Syndromes

Other Information

ATC CodeN01BB04
Related LinksWikipediaDrugBankKEGG